Table 8.
Treatment with Doses | Experimental Model | Major Findings (Including Molecular Changes) |
References |
---|---|---|---|
NSO (2 mL/kg BW, p.o.) | Cisplatin (CP)-induced gastrointestinal dysfunction in rats | ↓BBM enzyme activities and BBMV; ↓carbohydrate metabolism enzyme activities and enzymatic as well as non-enzymatic antioxidant parameters in the intestine; ↑intestinal redox and metabolic status; restored BBM integrity | [196] |
TQ (1.5 mg/kg BW) |
CP-induced gastrointestinal damage in rats | ↓CP induced specific activities of BBM marker enzymes; restoring the redox and metabolic status of intestinal mucosal tissue and preserving intestinal histoarchitecture | [197] |
NSO (2 mL/kg BW, p.o.) and TQ (1.5 mg/kg BW, p.o.), for 14 days | CP-induced intestinal toxicity in rats | ↑BBM enzyme activities; ↑carbohydrate metabolism enzymes and the enzymatic as well as non-enzymatic parameters of antioxidant defense system in the intestinal mucosa | [198] |
Pectic polysaccharide of seed (200 mg/kg BW for 10 days) |
Acetic acid-induced gastric ulcers in rats. | ↑Gastric mucin content, Cox-2, PGE2, ERK-2, MMP-2; ↓MMP-9 levels; ↓H+/K+-ATPase and free radical-mediated oxidation and cellular damages that improved speed and quality of ulcer healing | [199] |
TQ (5 mg/kg) |
Fasting-induced rabbit gastric ulcer model | ↓ Volume and the total acidity of gastric secretion | [201] |
NSO (0.2 mL/kg/day for 5 days) |
Male Wistar albino rats with ischemia/ reperfusion injury (colonic anastomosis model) | ↑Serum hydroxyproline levels, IL-6 level; ↓tissue levels and serum levels of TNF-α; ↓ edema and inflammatory cell infiltration; significant difference in Chiu classification | [202] |
Dosin (6 g/day of black cumin seed and 12 g/day of honey) |
Patients with H. pylori infection | Negative UBT after intervention; ↓median and interquartile range of total dyspepsia symptoms | [203] |
Seed powder (2 g for 6 weeks) | Patients with moderate ulcerative colitis | ↓ Stool frequency | [204] |